[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016-2020 World APTT Testing Market: Ambulatory Centers, Commercial Labs, Hospitals, Physician Offices, POC/Point-of-Care Locations-Competitive Landscape, Country Segment Forecasts, Innovative Technologies, Instrumentation Review

March 2016 | 198 pages | ID: 242C61859B9EN
Venture Planning Group

US$ 3,080.00 US$ 3,850.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and APTT testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the APTT testing closer to the patient, creating additional opportunities and challenges for suppliers. This report presents a detailed analysis of the APTT testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment. The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 198 pages and 8 tables
1. AIDS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

2. ADENOVIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)

3. AEROMONAS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

4. ANTHRAX/BACILLUS ANTHRACIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

5. ARBOVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

6. BABESIOSIS

a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

8. BLASTOCYSTIS HOMINIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

9. BRUCELLA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

10. CAMPYLOBACTER

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

11. CANDIDA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

12. CHAGAS DISEASE

a. Background

13. CHANCROID

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

14. CHLAMYDIA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

15. CLOSTRIDIUM DIFFICILE

a. Background
b. Diagnostic Tests
c. Drugs and Vaccines

16. CORONAVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

17. COXSACKIEVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

18. CREUTZFELDT-JAKOB’S DISEASE

a. Background
b. Diagnostic Tests
c. Vaccines

19. CRYPTOSPORIDIUM PARVUM

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

20. CYCLOSPORA CAYETANENSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

21. CYTOMEGALOVIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

22. EBOLA VIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

23. E. COLI

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

24. ECHOVIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

25. ENCEPHALITIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

26. ENTEROVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

27. EPSTEIN-BARR VIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

28. GIARDIA LAMBLIA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

29. GONORRHEA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

30. GRANULOMA INGUINALE

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

31. HANTAVIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

32. HELICOBACTER PYLORI

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

33. HEPATITIS

a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
e. Vaccines and Drugs

34. HERPES SIMPLEX VIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

35. HUMAN HERPES VIRUS-6 (HHV-6)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

36. INFLUENZA VIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

37. LEGIONELLA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

38. LYME DISEASE

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

39. LYMPHOGRANULOMA VENEREUM (LGV)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

40. MALARIA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

41. MEASLES (RUBEOLA)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

42. MENINGITIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

43. MICROSPORIDIUM

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

44. MONONUCLEOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

45. MUMPS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

46. MYCOPLASMA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

47. PAPILLOMAVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

48. PARVOVIRUS B19

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

49. PNEUMONIA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

50. POLYOMAVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

51. PSEUDOMONAS AERUGINOSA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

52. RABIES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

53. RESPIRATORY SYNCYTIAL VIRUS (RSV)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

54. RHINOVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

55. ROTAVIRUS (REOVIRUS)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

56. RUBELLA(MEASLES)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

57. SALMONELLOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

58. SEPTICEMIA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

59. SHIGELLOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

60. STAPHYLOCOCCUS AUREUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

61. STREPTOCOCCI

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

62. SYPHILIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

63. TOXOPLASMOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

64. TRICHOMONAS VAGINALIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

65. TUBERCULOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

66. VIBRIO

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

67. WEST NILE VIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

68. YERSINA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing InfluenzaTests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing MycoplasmaTests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing PneumoniaTests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing RotavirusTests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing SyphilisTests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests


More Publications